Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Color appearance under chromatic adaptation varied along theoretically significant axes in color space.
Reticuloendotheliosis virus
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Systemic therapy for advanced or recurrent endometrial carcinoma.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Systemic therapy for advanced or recurrent endometrial carcinoma.
Systemic therapy for advanced or recurrent endometrial carcinoma. Curr Oncol Rep. 1999 Sep; 1(1):47-53.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma
Disease-Free Survival
Endometrial Neoplasms
Female
Humans
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Severity of Illness Index
Survival Analysis
authors with profiles
Gini Fleming